Rise in infertility rate, an increase in trend of delayed pregnancies, a surge in IVF success rate, and rise in disposable income worldwide are the factors that are anticipated to boost the growth of the global IVF services market during the forecast period. However, factors such as complications associated with IVF treatment, high cost, and low awareness level for IVF in some underdeveloped regions hinder the growth of the market. Conversely, an increase in fertility tourism and a surge in number of fertility clinics are anticipated to offer lucrative opportunities for market growth in the near future.
The global IVF services market is segmented into cycle type, end user, and region. Depending on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, it is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. Region wise, it is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia, Denmark, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, Thailand, New Zealand, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all regions is provided to determine the prevailing opportunities.
- Key players are profiled to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Cycle Type
- Fresh IVF Cycles (Non-donor)
- Thawed IVF Cycles (Non-donor)
- Donor Egg IVF Cycles
By End User
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Denmark
- Russia
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- New Zealand
- Thailand
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Ambroise Paré Group
- amedes MVZ Cologne GmbH
- AMP Center St Roch
- AVA Clinic Scanfert
- Bangkok IVF center
- Bangkok IVF center (Bangkok Hospital)
- Betamedics
- Biofertility Center
- Bloom Fertility and Healthcare
- Bloom Fertility Center
- Bourn Hall Fertility Center
- Bourn Hall International
- Cardone Reproductive Medicine and Infertility, LLC
- Center for Advanced Reproductive Medicine and Infertility
- CHA Fertility Center
- Chelsea and Westminster Hospital (Assisted Conception Unit)
- Cloudnine Fertility
- Conceptions Reproductive Associates of Colorado
- Cyprus IVF Centre
- Dansk Fertilitetsklinik
- EUVITRO S.L.U.
- Fakih IVF Fertility Center
- Fertility and Gynecology Center Monterey Bay IVF
- Fertility Associates
- Fertility Center Berlin
- Fertility Center of San Antoni
- Fertility First
- FIV Marbella
- Fivet Centers Prof. Zech
- Flinders Reproductive Medicine Pty Ltd
- Genea Oxford Fertility Limited
- Heidelberg University Hospital
- Houston Fertility Center
- International Centre for Reproductive Medicine, ICRM
- IVF Canada
- IVF NAMBA Clinic
- IVF Panama Center for Reproduction Punta Pacífica
- IVF Spain
- IVI Panama
- Ivinsemer
- KL Fertility & Gynaecology Centre
- Lifesure Fertility and Gynaecology Centre
- LIV Fertility Center
- Manipal Fertility
- Maria Fertility Hospital
- MD Medical Group
- Medfem Fertility Clinic
- Monash IVF Wesley Hospital Auchenflower
- Morpheus Life Sciences Pvt. Ltd.
- New hope fertility center
- Oak Medical Group/Oak Clinic
- OVA IVF Clinic Zurich
- Procrea Fertility
- RAPRUI Srl
- Repromed
- SAFE Fertility Center
- Sanno Hospital
- Servy Massey Fertility Institute
- Shanghai Ji Ai Genetics & IVF Institute
- Shanghai United Family Hospital
- Sher Institute for Reproductive Medicine (SIRM)
- Southend Fertility and IVF
- StorkKlinik (Stork IVF Clinic)
- The ARC-STER Center
- The Bridge Centre
- The Cape Fertility Clinic
- The Hugh Wynter Fertility Management Unit
- The Lister Fertility Clinic
- The Montreal Fertility Center
- Thomson Medical Pte. Ltd.
- Trianglen Fertility Clinic
- TRIO Fertility
- Virtus Health
- Vitanova
- VivaNeo - Medical Center Kinderwens
- Wunschkinder
Table of Contents
Executive Summary
In-vitro Fertilization (IVF) Services Report forecasts that the global market is expected to garner market to reach $11.3 billion by 2021.United Stateswould continue to lead the market through 2021 and would have 321.7 thousand IVF cycles performed in 2021. Globally,Indiais projected to register highest growth both in terms of number of cycles and revenue.The key factors that influence the growth of IVF cycles include, delayed pregnancy; a factor that is increasingly gaining prominence in developed economies, rise in infertility rates and increase in healthcare expenditures. Moreover, growing acceptance of the 3-parent IVF technique further contributing to the market growth. These factors would facilitate the number of cycles performed to reach 3,122.2 thousands by 2021, globally. On contrary, stringent regulations, limited success ratio and high costs of treatment would limit the market growth. Active initiatives by government, such as IVF refund programs, donor egg IVF programs, development of cost-effective IVF techniques and increasing popularity of fertility tourism would spur the market growth.
Geographically,the United States,China, andIndia, collectively holds about 42% of the market (IVF cycles) share due to increased rate of infertility and practices of embryo banking cycles, rising fertility tourism, and delayed parenthood decisions. On the other hand, Turkey, Israel, Brazil, Mexicowould emerge as key fertility tourism destinations during the forecast period mainly due to favorable government regulations and economic availability of skilled workforce and hospitality services.
Key Findings of In-vitro Fertilization (IVF) Services Market:
In India, fertility clinics and hospitals segment collectively accounted for about 4/5th of the revenue generated in 2014
Middle East accounted for about 65% revenue share of the LAMEA IVF market
The Asia-Pacific IVF market is expected to grow at a promising CAGR of 8.9% from 2015 to 2021 in terms of volume
China leads the Asia Pacific IVF market with about 44% volume share
Key players profiled in this report included Fertility and Gynecology Center, Monterey Bay IVF, Conceptions Reproductive Associates, Toronto Center for Advanced reproductive Technology Ltd., Liv Fertility Center inPuerto Vallarta, Klinikum Stuttgart, Heidelberg University Hospital, Clinique de la Muette, The Bridge Center,Sun Pharmaceuticals, Cadila Healthcare Ltd., LG Lifesciences, Vitrolife AB., EMD Serono, Inc., Thermo Fisher Scientific Inc., Genea Biomedx, Clinica Anglo Americana, Cyprus IVF Center Lifesure Fertility & Gynecology Center and others.
Companies Mentioned
- Gynecology Center
- Monterey Bay IVF
- Conceptions Reproductive Associates
- Toronto Center for Advanced reproductive Technology Ltd.
- Liv Fertility Center inPuerto Vallarta
- Klinikum Stuttgart
- Heidelberg University Hospital
- Clinique de la
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...